What is FTD Registry?
FTD Registry operates as a specialized digital infrastructure designed to bridge the gap between patients, caregivers, and the scientific community. By aggregating longitudinal data and real-world insights from those impacted by frontotemporal degeneration, the platform serves as a critical repository for clinical research. Its market position is defined by its ability to accelerate the recruitment process for therapeutic trials, effectively reducing the time-to-market for potential treatments. The registry functions as a collaborative ecosystem, fostering transparency and community-led progress in a field historically underserved by traditional pharmaceutical pipelines.
How much funding has FTD Registry raised?
FTD Registry has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in FTD Registry
PPP
Public-Private Partnership
What's next for FTD Registry?
With this late-stage capital, the FTD Registry is expected to expand its outreach initiatives and enhance its data analytics capabilities. The strategic roadmap likely involves deepening partnerships with global research institutions and pharmaceutical entities to streamline the identification of eligible candidates for upcoming clinical studies. By leveraging this investment, the organization aims to solidify its role as the primary nexus for FTD-related scientific inquiry, ultimately driving the development of disease-modifying therapies. Future growth will likely focus on integrating advanced diagnostic data and expanding the registry's global footprint to ensure a more diverse and representative patient cohort for ongoing research efforts.
See full FTD Registry company page
